Zhejiang Canaan Technology Limited

Shenzhen Stock Exchange 300412.SZ

Zhejiang Canaan Technology Limited Operating Income Margin for the year ending December 31, 2023: -3.40%

Zhejiang Canaan Technology Limited Operating Income Margin is -3.40% for the year ending December 31, 2023, a -207.57% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Zhejiang Canaan Technology Limited Operating Income Margin for the year ending December 31, 2022 was 3.16%, a -78.35% change year over year.
Zhejiang Canaan Technology Limited Operating Income Margin for the year ending December 31, 2021 was 14.60%, a 63.99% change year over year.
Zhejiang Canaan Technology Limited Operating Income Margin for the year ending December 31, 2020 was 8.91%, a -43.15% change year over year.
Zhejiang Canaan Technology Limited Operating Income Margin for the year ending December 31, 2019 was 15.66%, a 72.63% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Shenzhen Stock Exchange: 300412.SZ

Zhejiang Canaan Technology Limited

CEO	Mr. Zheng Fang
IPO Date	Dec. 31, 2014
Location	China
Headquarters	Park Avenue
Employees	1,749
Sector	Health Care
Industries Pharmaceuticals Machinery

Description

Zhejiang Canaan Technology Co., Ltd. engages in the development, manufacture, and marketing of pharmaceutical equipment in China. The company offers OSD products, such as dispensing, high shear mixer, roller compactor, fluid bed, mill, pelleting, lender, pharma lifter, tablet press, coater, capsule filling, washing machine, and pharma bin and series parts, as well as OEB equipment and isolators, R&D machines, APIs, packaging, water systems, extraction and reactor, and warehouse products. It primarily serves pharmaceutical industry. Zhejiang Canaan Technology Co., Ltd. was founded in 2000 and is based in Wenzhou, China.

Key trends

Past 5 years